Viscerotropic disease: case definition and guidelines for collection, analysis, and presentation of immunization safety data.
作者信息
Gershman Mark D, Staples J Erin, Bentsi-Enchill Adwoa D, Breugelmans J Gabrielle, Brito Glacus S, Camacho Luiz Antonio Bastos, Cottin Pascale, Domingo Cristina, Durbin Anna, Gascon Joaquim, Guenaneche Fouzia, Hayes Edward B, Jelenik Zsuzsanna, Khromava Alena, Martins Reinaldo de Menezes, Wilson Mario Masana, Massy Nathalie, Nasidi Abdulsalami, Niedrig Matthias, Sherwat Adam, Tsai Theodore, Vilella Anna, Wilson Mary Elizabeth, Kohl Katrin S
机构信息
Division of Global Migration and Quarantine, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road, N.E., MS-E03, Atlanta, GA 30333, USA.
出版信息
Vaccine. 2012 Jul 13;30(33):5038-58. doi: 10.1016/j.vaccine.2012.04.067. Epub 2012 May 4.
Abstract
摘要
相似文献
1
Viscerotropic disease: case definition and guidelines for collection, analysis, and presentation of immunization safety data.嗜内脏性疾病：免疫接种安全性数据收集、分析及呈现的病例定义与指南
Vaccine. 2012 Jul 13;30(33):5038-58. doi: 10.1016/j.vaccine.2012.04.067. Epub 2012 May 4.
2
Low birth weight: Case definition & guidelines for data collection, analysis, and presentation of maternal immunization safety data.低出生体重：病例定义及孕产妇免疫安全性数据收集、分析和呈现指南。
Vaccine. 2017 Dec 4;35(48 Pt A):6492-6500. doi: 10.1016/j.vaccine.2017.01.049.
3
Antenatal bleeding: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data.产前出血：免疫接种安全性数据的病例定义及数据收集、分析和呈现指南。
Vaccine. 2017 Dec 4;35(48 Pt A):6529-6537. doi: 10.1016/j.vaccine.2017.01.081.
4
Dysfunctional labor: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.产程异常：免疫接种安全性数据的病例定义及数据收集、分析和呈现指南。
Vaccine. 2017 Dec 4;35(48 Pt A):6538-6545. doi: 10.1016/j.vaccine.2017.01.050.
5
Respiratory distress in the neonate: Case definition & guidelines for data collection, analysis, and presentation of maternal immunization safety data.新生儿呼吸窘迫：病例定义及孕产妇免疫安全数据收集、分析和报告指南
Vaccine. 2017 Dec 4;35(48 Pt A):6506-6517. doi: 10.1016/j.vaccine.2017.01.046.
6
Gestational diabetes mellitus: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.妊娠期糖尿病：免疫接种安全性数据的病例定义及数据收集、分析和呈现指南。
Vaccine. 2017 Dec 4;35(48 Pt A):6555-6562. doi: 10.1016/j.vaccine.2017.01.043.
7
Spontaneous abortion and ectopic pregnancy: Case definition & guidelines for data collection, analysis, and presentation of maternal immunization safety data.自然流产和异位妊娠：病例定义及孕产妇免疫安全性数据收集、分析和呈现指南。
Vaccine. 2017 Dec 4;35(48 Pt A):6563-6574. doi: 10.1016/j.vaccine.2017.01.047.
8
Fetal growth restriction: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.胎儿生长受限：免疫接种安全性数据的病例定义及数据收集、分析和呈现指南。
Vaccine. 2017 Dec 4;35(48 Pt A):6546-6554. doi: 10.1016/j.vaccine.2017.01.042.
9
Can reporting of adverse drug reactions create safer systems while improving health data?药物不良反应报告能否在改善健康数据的同时创建更安全的系统？
CMAJ. 2015 Aug 11;187(11):789-790. doi: 10.1503/cmaj.150057. Epub 2015 May 4.
10
Congenital microcephaly: Case definition & guidelines for data collection, analysis, and presentation of safety data after maternal immunisation.先天性小头畸形：病例定义及孕产妇免疫后安全性数据的收集、分析和呈现指南。
Vaccine. 2017 Dec 4;35(48 Pt A):6472-6482. doi: 10.1016/j.vaccine.2017.01.044.
引用本文的文献
1
Adverse events following immunization (AEFI) with fractional one-fifth and one-half doses of yellow fever vaccine compared to full dose in children 9-23 months old in Uganda, 2019-2020 - Preliminary report.2019-2020 年乌干达 9-23 月龄儿童接种五分之一和二分之一剂量黄热病疫苗与全剂量相比的免疫后不良反应（AEFI）-初步报告。
Vaccine. 2024 Sep 17;42(22):126197. doi: 10.1016/j.vaccine.2024.126197. Epub 2024 Aug 15.
2
A Perspective on Current Flavivirus Vaccine Development: A Brief Review.当前黄病毒疫苗开发的观点：简要综述。
Viruses. 2023 Mar 28;15(4):860. doi: 10.3390/v15040860.
3
Yellow Fever Vaccine-Associated Viscerotropic Disease among Siblings, São Paulo State, Brazil.巴西圣保罗州黄热病疫苗相关内脏疾病在兄弟姐妹间的传播
Emerg Infect Dis. 2023 Mar;29(3):493-500. doi: 10.3201/eid2903.220989.
4
The Present and Future of Yellow Fever Vaccines.黄热病疫苗的现状与未来
Pharmaceuticals (Basel). 2021 Sep 1;14(9):891. doi: 10.3390/ph14090891.
5
Multisystem inflammatory syndrome in children and adults (MIS-C/A): Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.儿童和成人多系统炎症综合征（MIS-C/A）：病例定义和免疫安全数据收集、分析和报告指南。
Vaccine. 2021 May 21;39(22):3037-3049. doi: 10.1016/j.vaccine.2021.01.054. Epub 2021 Feb 25.
6
Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccine.自身免疫性抗体针对 I 型干扰素可能导致黄热病减毒活疫苗的不良反应。
J Exp Med. 2021 Apr 5;218(4). doi: 10.1084/jem.20202486.
7
Invasive aspergillosis complication in yellow fever vaccine induced viscerotropic disease.黄热病疫苗诱发的嗜内脏型疾病中的侵袭性曲霉病并发症。
Med Mycol Case Rep. 2020 Sep 17;30:12-14. doi: 10.1016/j.mmcr.2020.09.002. eCollection 2020 Dec.
8
Viscerotropic disease and acute uveitis following yellow fever vaccination: a case report.黄热病疫苗接种后内脏嗜性疾病和急性葡萄膜炎：病例报告。
BMC Infect Dis. 2020 Feb 10;20(1):116. doi: 10.1186/s12879-020-4838-x.
9
Disease Resurgence, Production Capability Issues and Safety Concerns in the Context of an Aging Population: Is There a Need for a New Yellow Fever Vaccine?老龄化背景下的疾病复发、生产能力问题及安全担忧：是否需要新型黄热病疫苗？
Vaccines (Basel). 2019 Nov 8;7(4):179. doi: 10.3390/vaccines7040179.
10
Notes from the Field: Investigation of Patients Testing Positive for Yellow Fever Viral RNA After Vaccination During a Mass Yellow Fever Vaccination Campaign - Angola, 2016.实地记录：2016年安哥拉大规模黄热病疫苗接种运动期间接种疫苗后黄热病病毒RNA检测呈阳性患者的调查
MMWR Morb Mortal Wkly Rep. 2017 Mar 17;66(10):282-283. doi: 10.15585/mmwr.mm6610a5.
本文引用的文献
1
Elderly subjects have a delayed antibody response and prolonged viraemia following yellow fever vaccination: a prospective controlled cohort study.老年人接种黄热病疫苗后抗体反应延迟且病毒血症持续时间延长：一项前瞻性对照队列研究。
PLoS One. 2011;6(12):e27753. doi: 10.1371/journal.pone.0027753. Epub 2011 Dec 7.
2
Infant meningoencephalitis caused by yellow fever vaccine virus transmitted via breastmilk.因母乳传播的黄热病疫苗病毒引起的婴儿脑膜脑炎。
J Pediatr (Rio J). 2011;87(3):269-72. doi: 10.2223/JPED.2067. Epub 2011 Apr 1.
3
Case report: probable transmission of vaccine strain of yellow fever virus to an infant via breast milk.病例报告：婴儿通过母乳感染黄热病毒疫苗株。
CMAJ. 2011 Mar 8;183(4):E243-5. doi: 10.1503/cmaj.100619. Epub 2011 Feb 7.
4
Yellow fever surveillance and outbreak response: revision of case definitions, October 2010.黄热病监测与疫情应对：病例定义修订，2010年10月
Wkly Epidemiol Rec. 2010 Nov 19;85(47):465-72.
5
Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).黄热病疫苗：免疫实践咨询委员会（ACIP）的建议。
MMWR Recomm Rep. 2010 Jul 30;59(RR-7):1-27.
6
A case of yellow fever vaccine-associated viscerotropic disease in Ecuador.厄瓜多尔一起黄热病疫苗相关内脏疾病病例。
Am J Trop Med Hyg. 2010 Apr;82(4):740-2. doi: 10.4269/ajtmh.2010.09-0570.
7
CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials.CONSORT 2010 声明：平行组随机试验报告的更新指南。
Ann Intern Med. 2010 Jun 1;152(11):726-32. doi: 10.7326/0003-4819-152-11-201006010-00232. Epub 2010 Mar 24.
8
Transmission of yellow fever vaccine virus through breast-feeding - Brazil, 2009.通过母乳喂养传播黄热病疫苗病毒 - 巴西，2009 年。
MMWR Morb Mortal Wkly Rep. 2010 Feb 12;59(5):130-2.
9
Transfusion-related transmission of yellow fever vaccine virus--California, 2009.2009 年加利福尼亚州因输血导致的黄热病疫苗病毒传播。
MMWR Morb Mortal Wkly Rep. 2010 Jan 22;59(2):34-7.
10
Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses.基于黄热病 17D 疫苗的嵌合疫苗在登革热、西尼罗河和日本脑炎病毒防治方面的临床前和临床研究进展。
Vaccine. 2010 Jan 8;28(3):632-49. doi: 10.1016/j.vaccine.2009.09.098. Epub 2009 Oct 4.
Zotero 插件